This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ISS Proxy Advisory Services Recommends Stockholders Vote For Wynnefield’s Nominees

The Wynnefield Group, the largest stockholder in Crown Crafts Inc. (NASDAQ: CRWS), today announced that leading independent proxy voting and corporate governance advisory firms ISS Proxy Advisory Services and PROXY Governance, Inc. have recommended that Crown Crafts stockholders vote Wynnefield’s GOLD proxy card in connection with the Company’s August 10, 2010 Annual Meeting of Stockholders.

ISS recommended that Crown Crafts stockholders vote on Wynnefield’s GOLD proxy card for both Wynnefield nominees – Jon C. Biro and Melvin L. Keating. ISS noted that “ both dissident nominees are seasoned executives that have a high degree of finance acumen and multiple public board experience” (emphasis added).

In determining that change is warranted at Crown Crafts, ISS wrote of the management-endorsed Board majority that, “ We have also noted a history of problematic compensation and governance practices which seem poorly aligned with the long-term interests of shareholders” (emphasis added).

In its recommendation for Wynnefield’s nominees, ISS pointed to several factors, including:
  • Lavish Employment and Severance Agreements. ISS criticized the Company’s employment agreements and golden parachutes, stating that, “The provisions associated with these executives’ change in control agreements are misaligned with maximizing shareholder return and best corporate governance practices. It appears that these provisions seem to accentuate the control that Mr. Chestnut has over the company.”
  • Crown Crafts’ Valuation Lags Peers. ISS wrote that, “CRWS trades at a material discount to its peers and the discount has widened in the last year.”
  • Lackluster Financial Performance. The analysis concluded that from 2006 to 2010 “… it appears that organic revenues have declined from $72.6 million to $69.8 million (a negative 1.0 percent compounded annual growth rate). This supports Wynnefield’s argument that CRWS management has failed to grow the organic business.”“The anemic revenue growth of the total company, even with [the recent] acquisitions, also supports the dissident’s contention that the organic business has been stagnant at best.”
  • Questionable Corporate Governance Motivations. Of the Board’s recent announcements regarding its “poison pill”, ISS wrote, “In part in response to the dissident’s concerns about the company’s governance provisions, the board determined this week to terminate as of July 31, 2010, the shareholders rights plan (“poison pill”)… While we commend the board for taking this action, the time and reactive nature of the board’s action calls into question the board’s motivations.”

ISS concluded its analysis by noting that “it appears dissident activism may have been largely responsible for triggering the strategic review process as well as the announcements about the dissolution of the longstanding poison pill, the focus on growing international revenues and management’s intentions to broaden awareness of the company by actively engage (sic) in investor/industry conferences” and further said that the “CRWS board may benefit from the addition of experienced directors having specific strategic, governance and transaction related expertise to face growth and business challenges going forward.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
CRWS $8.06 0.00%
AAPL $123.38 0.00%
FB $95.29 0.00%
GOOG $628.00 0.00%
TSLA $264.82 0.00%


Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs